The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

Measles Cases in South Carolina Rise by 6 to 979

Measles cases in South Carolina surged to 979 on Tuesday, state health data ⁠showed, including six additional infections since Friday.

Severe Infection Linked to Long-term IBD Risk

Severe infections requiring hospitalization are associated with a markedly increased long-term IBD risk, with immune-related genetic variants modifying susceptibility.

Company Files for Approval of New Pustular Psoriasis Rx

Imsidolimab is a monoclonal antibody that inhibits interleukin-36 receptor signaling and is administered intravenously.

Study Reveals Gaps in ED Syphilis Screening

Despite increased STI testing in US emergency departments from 2020 to 2024, syphilis screening is often missed, particularly among female and insured patients.

RSV Tamps Down Rhinovirus Coinfection in Infants

Order of infection appeared to affect disease severity in nasal tissue models.

Molluscum Rx: Recommendations From a Pediatric Dermatologist

Dr Swanson tells families that almost all kids get poxvirus-caused bumps and while treatment isn’t mandatory, options include topical cantharidin, berdazimer gel, and intralesional candida injections.

Todays Updates

Treating Depression: Crucial for Recovery From Fibromyalgia

In patients with newly diagnosed fibromyalgia who have prominent symptoms of anxiety and depression, remission of depression — not pain reduction alone — determines clinical improvement.

The Boom in ADHD Coaching Has Few Rules

Most ADHD coaches do not have behavioral health training, a study finds, but experts say peer support can help people navigate living with the condition.

SBRT May Beat Brachytherapy in Prostate Cancer

In the long term, stereotactic body radiotherapy carries a lower risk for biochemical failure vs high-dose rate brachytherapy for men with intermediate-risk prostate cancer.

Todays Updates

Treating Depression: Crucial for Recovery From Fibromyalgia

In patients with newly diagnosed fibromyalgia who have prominent symptoms of anxiety and depression, remission of depression — not pain reduction alone — determines clinical improvement.

The Boom in ADHD Coaching Has Few Rules

Most ADHD coaches do not have behavioral health training, a study finds, but experts say peer support can help people navigate living with the condition.

SBRT May Beat Brachytherapy in Prostate Cancer

In the long term, stereotactic body radiotherapy carries a lower risk for biochemical failure vs high-dose rate brachytherapy for men with intermediate-risk prostate cancer.

Latest News

Measles cases in South Carolina surged to 979 on Tuesday, state health data ⁠showed, including six additional infections since Friday.

Severe infections requiring hospitalization are associated with a markedly increased long-term IBD risk, with immune-related genetic variants modifying susceptibility.

Imsidolimab is a monoclonal antibody that inhibits interleukin-36 receptor signaling and is administered intravenously.

Despite increased STI testing in US emergency departments from 2020 to 2024, syphilis screening is often missed, particularly among female and insured patients.

Order of infection appeared to affect disease severity in nasal tissue models.

Dr Swanson tells families that almost all kids get poxvirus-caused bumps and while treatment isn’t mandatory, options include topical cantharidin, berdazimer gel, and intralesional candida injections.

News All Time

Flu Shot May Boost Survival in Patients With Cancer on ICIs

Patients with advanced cancer receiving influenza vaccination during immunotherapy had longer survival in a Swedish study, with no increase in immune-related toxicities.

Measles Cases in South Carolina Rise by 11 to 973

Measles cases in South Carolina surged to 973 on Friday, state ⁠health data showed, including 11 additional infections since Tuesday.

Going Home: Discharge Tips for CMC Patients

The number of children with medical complexity is growing and an efficient discharge requires a team approach. Here is how to make the transition successful.

Novel Combination Therapy: Breakthrough in Brain Metastases?

The combination of stereotactic RT or radiosurgery with immunotherapy or targeted therapy shows manageable toxicity and improved local control and clinical benefit in patients with brain metastases.

Pediatric Rheum Survey Shows Need to Improve Vaccine Reviews

A consensus statement with more specific guidance on communication practices may help standardize approaches to vaccine-related communication with families, author says.

Epinephrine Nasal Spray Promising for Urticaria Flares

In a phase 2 trial, patients having an urticaria exacerbation who used the spray report better hive and pruritus scores than the placebo group.

What’s at Issue in the FDA’s Request to Withdraw Avacopan?

European regulators are also conducting a review of avacopan. The issue appears to involve data from the pivotal ADVOCATE trial and questions of liver safety.

RSV Hits Harder in Kids With Asthma

Tests of tissue models show faster spread of virus in children with asthma than in nonasthma control participants.

Patient Preferences Drive Treatment for Allergic Rhinitis

Patients with pollen-related allergic rhinitis prefer on demand antihistamines, with treatment preferences differing markedly by age group, new research finds.

Early Top-Down Therapy May Modify Course of Crohn’s Disease

Starting biologic therapy at diagnosis, rather than escalating later, may significantly reduce complications and hospitalizations in Crohn’s disease, according to new data.

FDA Approves New Topical for Atopic Dermatitis

Difamilast is the third PDE4 inhibitor approved by the FDA for treating atopic dermatitis.

Protective Clothing, Low-Cost Sunscreens May Cut Expenses

The annual cost of recommended sunscreen use varies by up to 36-fold, depending on unit price and concurrent sun-protective behaviors.

HER2 Therapy for Biliary Cancer Approved by UK Regulator

The MHRA approved a first-in-class bispecific antibody for HER2-positive biliary tract cancer, offering a new line of therapy for patients who have progressed on standard care.

Gluten Sensitivity Without Celiac Disease Common in IBS

About 30% of young adults with irritable bowel syndrome report gluten sensitivity without celiac disease or wheat allergy and improve on a gluten-free diet.

Measles Cases in South Carolina Rise by 12 to 962, State Health Department Says

South Carolina reported a surge to 962 measles cases on Tuesday, state health data showed, including ⁠12 additional infections since Friday, as officials warned the widening...

Urgent TRUE METRIX Glucose Meter Alert Updates Error Message

As currently written, the instructions could potentially lead to delayed treatment of high glucose levels.

Recommended News For You

Cancer mortality continuing to decline, says report

Oral drug combination extends progression-free survival in advanced ER-positive breast cancer

Beyond What Is Visible in Myelofibrosis?

Use of marijuana and alcohol simultaneously is associated with worse outcomes.

Thriving while surviving: Understanding the social needs of cancer survivors

King Charles' Cancer; COVID Vax Now or Later; Was RFK Jr. a Drug Dealer?

Analysis of 2021 data shows new cancer diagnoses did not rebound as expected following pandemic

Recommended Articles For You

Late Effects of Immunotherapy in Chronic Melanoma Survivorship with Repurposed Drugs 

Unlocking the Potential of Cancer Antigen 19-9 for Early Detection 

Vaso Occlusive Crisis: Understanding the Painful Reality of Sickle Cell Disease 

Landmark Medical Oncology Trials Redefining Early Breast Cancer Management 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?

2.

The importance of breast cancer screening

3.

Breast cancer-related fatigue: The benefits of adapted physical activity

4.

Gene therapies for BCG-unresponsive bladder cancer have high response rates.

5.

With the use of a novel sequencing technique, pediatric bone marrow transplant mortality can be predicted by analyzing lung microbiomes.

1.

Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms

2.

The Impact of Microadenoma on Hormonal Health

3.

Unlocking the Mysteries of the Axillary Vein: Exploring its Role in Human Anatomy

4.

Exploring the Causes and Treatments of Thrombocytopenia: A Comprehensive Guide

5.

Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

2.

Should We Use DARA Up Front As First-Line Therapy in MM?

3.

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

5.

Navigating the Complexities of Ph Negative ALL - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot